Aurobindo Pharma LtdPharmaceuticalsINE406A01037Consolidated₹1734.00+44.00 (+2.60%)Jun-26
Valuation
Market Cap₹99.77K Cr
TTM PE27.09x
Forward PE26.33x
PEG4.46
Book Value₹658.54
P/B2.63x
TTM EPS₹64.00
Fwd EPS₹65.85
TTM Revenue₹34.94K Cr
TTM PAT₹3.71K Cr
TTM EBITDA₹7.09K Cr
TTM EBIT₹5.23K Cr
Last Qtr PAT₹1,032.03 Cr
Last Qtr EBITDA₹1.88K Cr
Last Qtr EBIT₹1.39K Cr
Profitability
ROE9.79%
ROCE12.66%
TTM NPM10.62%
TTM EBITDA %20.28%
Curr OPM10.96%
Last OPM10.27%
Curr NPM—
Last NPM—
Curr EPS₹17.86
Last EPS₹15.86
Balance sheet
Equity₹58.08 Cr
Reserve₹37.83K Cr
Total Debt₹7,992.20 Cr
D/E0.21x
Interest %9.85%
Curr Interest₹101.66 Cr
Price / range
Close₹1734.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.60%
1W+3.23%
1M+5.41%
3M+20.11%
6M+36.64%
1Y+53.66%
2Y+12.69%
3Y+93.79%
5Y+132.38%
Diwali+45.36%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits